Toward meeting your research needs, Indivumed is pleased to announce we have complemented our high-quality immunohistochemistry (IHC) services by offering Fluorescent Multiplex IHC with Tyramide Signal Amplification. With this service, up to six targets of interest can be analyzed on one tissue section. Tyramide Signal Amplification ensures the highest sensitivity in fully automated multiplex staining, and whole-slide scans, including seven fluorescent layers, allow complex digital image analyses and long-term storage.
Please join us to explore the benefits of a career with Indivumed.
August 02, 2017
MedStar Health will collaborate with Indivumed to advance our understanding of the molecular basis of cancer through collection and analysis of biospecimens and clinical data, making possible new individualized diagnosis and treatment of cancer.Read More
April 11, 2017
Hamburg's First Mayor, Olaf Scholz, and international guests from science and business honored Indivumed at its 15-year anniversary.Read More
April 10, 2017
Indivumed founder and CEO, Dr. Hartmut Juhl, has been recognized by the AACR for his participation in the development and commercialization of the field of liquid biopsy research.Read More